Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Regional Health Properties | RHE | Sep 19, 2024 | 1.80 | +0.24 |
Regional Health Properties A Pref | RHE-A | Sep 19, 2024 | 0.51 | -8.91 |
Regional Management | RM | Sep 19, 2024 | 33.24 | +3.23 |
Regions Financial | RF | Sep 19, 2024 | 23.36 | +2.82 |
Regions Financial B Pref | RF-B | Sep 19, 2024 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | Sep 19, 2024 | 24.89 | +1.06 |
Regions Financial E Pref | RF-E | Sep 19, 2024 | 19.50 | +0.28 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Sep 19, 2024 | 26.12 | 0.00 |
Regis | RGS | Sep 19, 2024 | 25.83 | +10.86 |
Regulus Therapeutics | RGLS | Sep 19, 2024 | 1.71 | +5.56 |
Reinsurance Group of America | RGA | Sep 19, 2024 | 218.74 | +0.11 |
REIT Index ETF Vanguard | VNQ | Sep 19, 2024 | 98.18 | +0.02 |
Reitar Logtech | RITR | Sep 19, 2024 | 4.04 | 0.00 |
Rekor Systems | REKR | Sep 19, 2024 | 1.22 | +1.67 |
Relay Therapeutics | RLAY | Sep 19, 2024 | 7.86 | +3.69 |
Reliance | RS | Sep 19, 2024 | 286.14 | +3.26 |
Reliance Global | RELI | Sep 19, 2024 | 2.45 | -5.77 |
Relmada Therapeutics | RLMD | Sep 19, 2024 | 3.50 | +0.29 |
RELX ADR | RELX | Sep 19, 2024 | 48.13 | +1.60 |
Remitly Global | RELY | Sep 19, 2024 | 14.25 | +0.21 |
Renaissance Ipo ETF | IPO | Sep 19, 2024 | 43.19 | +0.86 |
RenaissanceRe | RNR | Sep 19, 2024 | 260.96 | -0.76 |
RenaissanceRe G Pref | RNR-G | Sep 19, 2024 | 18.77 | +1.08 |
RenaissanceRe Holding F Pref | RNR-F | Sep 19, 2024 | 25.00 | +0.73 |
Renalytix ADR | RNLX | Sep 19, 2024 | 0.29 | +1.07 |
Renasant | RNST | Sep 19, 2024 | 34.60 | +3.62 |
Reneo Pharmaceuticals | RPHM | Sep 19, 2024 | 1.51 | +0.67 |
ReNew Energy Global A Shares | RNW | Sep 19, 2024 | 6.57 | +1.23 |
Renn Fund | RCG | Sep 19, 2024 | 2.06 | +4.04 |
Renovaro Biosciences | RENB | Sep 19, 2024 | 0.54 | -0.68 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.